BioTek Instruments, Inc., a global leader in the development, manufacture and sale of microplate instrumentation for drug discovery and life science solutions, announces that its Synergy™ Mx Monochromator-based Microplate Reader is now DLReady™ certified for dual-luciferase assays. This certification, awarded by Promega Corporation, establishes the Synergy Mx as meeting the highest performance levels and standards for Promega’s Dual-Luciferase® Reporter (DLR™) Assay System – a widely used luminescence-based assay for measuring gene transcription and control in microplate format.

The DLR Assay System provides rapid quantitation of firefly and Renilla luciferase reporters in transfected cells or in cell-free transcription/translation reactions. The combination of two reporter assays in one system provides improved efficiency in less time with attomole sensitivities and no endogenous activity in the experimental host cells.

BioTek’s Synergy Mx Monochromator-based Microplate Reader with Ultra Fine-Tuned™ technology provides fluorescence, luminescence and absorbance performance normally only found in dedicated single-mode systems. The top- and bottom-read fluorescence system is fully monochromator-based and equipped with a bandpass selection system for added flexibility. A premium quadruple grating architecture guarantees the best level of wavelength discrimination and smooth spectral scans, and optional dual-reagent dispensers allow precise control of reagent additions and timing in Promega’s DLR Assay System as well as kinetic studies, ion channel assays and flash assays. Additionally, a cuvette port increases versatility by allowing for cuvette-based assays and comparisons to standard cuvette spectrophotometers. With its modular format, the required modes can be selected for specific laboratory needs and upgraded at any time as the needs change.

The Synergy Mx joins BioTek’s Synergy 2 and Synergy HT Multi-detection Microplate Readers and Synergy 4 Multi-Mode Microplate Reader with Hybrid Technology™; all previously awarded with Promega’s DLReady certification.

BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.

DLR and DLReady logo are trademarks of Promega Corporation. Dual-Luciferase is a trademark of Promega Corporation and is registered with the U.S. Patent and Trademark Office.

 

For further information, contact:

Chere Griffin, Account Executive
Shaw & Todd Advertising and Marketing Communications
908-668-1106 x15
cgriffin@shawtodd.com